This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
The inspection closed with the facility receiving an inspection classification of NAI
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Convergent action on AMR identified as an important area of intervention
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Subscribe To Our Newsletter & Stay Updated
